SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001636050-21-000048
Filing Date
2021-04-19
Accepted
2021-04-19 16:55:29
Documents
1
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161886571482336.html 4  
1 FORM 4 wf-form4_161886571482336.xml 4 4205
  Complete submission text file 0001636050-21-000048.txt   5874
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXOVANT SCIENCES, INC. 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018
Business Address
Pande Atul (Reporting) CIK: 0001643071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 21835206